MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:QTZM)

0.3500 UNCHANGED
Last Price Updated: 3:51 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.3500
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.3500
Today's Range 0.3500 - 0.3500
52wk Range 0.0025 - 5.040
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Quantumzyme Research Published in the Journal of Molecular Graphics & Modelling Study Highlights In Silico Enzyme Engineering Approach for Sustainable Drug Manufacturing
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme Research Published in the Journal of Molecular Graphics & Modelling Study Highlights In Silico Enzyme Engineering Approach for Sustainable Drug Manufacturing
SAN DIEGO, CA - February 12, 2026 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM) (the “Company”), a biotransformation company focused on sustainable enzyme-based solutions, today announced the... 
Via TheNewswire.com

Performance

YTD
-89.0%
-89.0%
1 Month
N/A
N/A
3 Month
-91.8%
-91.8%
6 Month
-77.3%
-77.3%
1 Year
+535.2%
+535.2%

More News

Read More
News headline image
Quantumzyme Announces Strategic Capital Structure Initiative, Corporate Rebranding Update, and Planned 4-for-1 Forward Stock Split
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme Announces Strategic Capital Structure Initiative, Corporate Rebranding Update, and Planned 4-for-1 Forward Stock Split
Via TheNewswire.com
Topics Artificial Intelligence
News headline image
Quantumzyme Featured on Cover of RSC Sustainability for Research in Enzyme Engineering for Ibuprofen Synthesis
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Featured on Cover of RSC Sustainability for Research in Enzyme Engineering for Ibuprofen Synthesis
Via TheNewswire.com
Topics Intellectual Property
News headline image
Quantumzyme to Attend 2026 BIO International Convention
Via NewMediaWire
Quantumzyme to Attend 2026 BIO International Convention
Via TheNewswire.com
News headline image
UPDATE: Quantumzyme Announces Next-Generation Enzyme Engineering Platform for More Efficient Pharmaceutical Manufacturing
Via NewMediaWire
UPDATE: Quantumzyme Announces Next-Generation Enzyme Engineering Platform for More Efficient Pharmaceutical Manufacturing
Via TheNewswire.com
News headline image
Quantumzyme Announces Next-Generation Enzyme Engineering Platform for More Efficient Pharmaceutical Manufacturing
Via NewMediaWire
Quantumzyme Announces Next-Generation Enzyme Engineering Platform for More Efficient Pharmaceutical Manufacturing
Via TheNewswire.com
News headline image
Quantumzyme Corp. Provides 2025 Corporate Update and Outlines Strategic Priorities for 2026
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Provides 2025 Corporate Update and Outlines Strategic Priorities for 2026
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Announces Memorandum of Understanding With Predictive Research Inc. to Explore AI-Enabled Applications in Green Chemistry and Biocatalysis
Via TheNewswire.com
Topics Artificial Intelligence
Quantumzyme Corp. Announces Memorandum of Understanding With Predictive Research Inc. to Explore AI-Enabled Applications in Green Chemistry and Biocatalysis
Via NewMediaWire
Topics Artificial Intelligence
News headline image
Quantumzyme to Engage With Industry Leaders at BioLogic Summit 2026, Reinforcing Commitment to AI-Driven Innovation
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme to Engage With Industry Leaders at BioLogic Summit 2026, Reinforcing Commitment to AI-Driven Innovation
Via TheNewswire.com
Topics Artificial Intelligence
News headline image
Quantumzyme Announces Board Approval for Strategic Name Change to Quantum Genesis AI
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme Announces Board Approval for Strategic Name Change to Quantum Genesis AI
Via TheNewswire.com
Topics Artificial Intelligence
News headline image
Quantumzyme to Showcase Sustainable Enzyme Engineering Innovations at CCE-2026
Via NewMediaWire
Quantumzyme to Showcase Sustainable Enzyme Engineering Innovations at CCE-2026
Via TheNewswire.com
News headline image
Quantumzyme Announces First Lab-Scale Sample of Green Ibuprofen Shipped for Industrial Validation
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Announces First Lab-Scale Sample of Green Ibuprofen Shipped for Industrial Validation
Via TheNewswire.com
Topics Intellectual Property
News headline image
Quantumzyme Expands AI-Driven Enzyme Engineering Platform to Broaden Green API Manufacturing Applications
Via NewMediaWire
Topics Economy Emissions

Frequently Asked Questions

Is QTZM publicly traded?
Yes, QTZM is publicly traded.
What exchange does QTZM trade on?
QTZM trades on the OTC Traded
What is the ticker symbol for QTZM?
The ticker symbol for QTZM is QTZM on the OTC Traded
What is the current price of QTZM?
The current price of QTZM is 0.3500
When was QTZM last traded?
The last trade of QTZM was at 02/13/26 03:51 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story